Prognostic potential of preoperative circulating tumor cells to predict the early progression recurrence in hepatocellular carcinoma patients after hepatectomy

被引：0
|
作者：
Zhan Lu
Hanghang Ni
Xihua Yang
Lihao Tan
Haixiao Zhuang
Yunning Mo
Xingyu Wei
Lunan Qi
Bangde Xiang
机构：
[1] Guangxi Medical University Cancer Hospital,Department of Hepatobiliary Surgery
[2] Ministry of Education,Key Laboratory of Early Prevention and Treatment for Regional High
[3] Guangxi Medical University,Frequency Tumors
[4] Chenzhou No. 1 People’s Hospital,Department of Surgical Oncology
[5] Guangxi Liver Cancer Diagnosis and Treatment Engineering and Technology Research Center,undefined
来源：
BMC Cancer | / 23卷
关键词：
Hepatocellular carcinoma; Circulating tumor cells; Hepatectomy; Early progression recurrence;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Detection of γ-OHPdG in circulating liver cells and its potential use as a prognostic biomarker in patients with hepatocellular carcinoma recurrence
    Aggarwal, Monika
    Zhu, Zizhao
    Gould, Sophie
    Johnson, Peter
    Beheshtian, Samira
    Fang, Hongbin
    Kallakury, Bhaskar
    Mueller, Susette C.
    He, Aiwu Ruth
    Chung, Fung-Lung
    CANCER RESEARCH, 2022, 82 (12)
  • [32] Single Hepatocellular Carcinoma: Preoperative MR Imaging to Predict Early Recurrence after Curative Resection
    An, Chansik
    Kim, Dong Wook
    Park, Young-Nyun
    Chung, Yong Eun
    Rhee, Hyungjin
    Kim, Myeong-Jin
    RADIOLOGY, 2015, 276 (02) : 433 - 443
  • [33] Preoperative Neutrophil to Lymphocyte Ratio and Prognostic Nutritional Index Predict Overall Survival After Hepatectomy for Hepatocellular Carcinoma
    Okamura, Yukiyasu
    Ashida, Ryo
    Ito, Takaaki
    Sugiura, Teiichi
    Mori, Keita
    Uesaka, Katsuhiko
    WORLD JOURNAL OF SURGERY, 2015, 39 (06) : 1501 - 1509
  • [34] Tumor budding is a meaningful prognostic marker in patients with hepatocellular carcinoma after curative hepatectomy
    Yang, Kaibo
    Wu, Kunjin
    Lei, Zitong
    Liu, Tong
    Zhang, Xing
    Li, Jing
    Yang, Kun
    Peng, Qiuting
    Lin, Ting
    Liu, Chang
    Qu, Kai
    PORTAL HYPERTENSION & CIRRHOSIS, 2024, 3 (02): : 86 - 95
  • [35] Preoperative Neutrophil to Lymphocyte Ratio and Prognostic Nutritional Index Predict Overall Survival After Hepatectomy for Hepatocellular Carcinoma
    Yukiyasu Okamura
    Ryo Ashida
    Takaaki Ito
    Teiichi Sugiura
    Keita Mori
    Katsuhiko Uesaka
    World Journal of Surgery, 2015, 39 : 1501 - 1509
  • [36] Circulating tumor DNA is a potential prognostic risk factor of recurrence in patients with hepatocellular carcinoma treated by liver transplantation.
    Jiang, Nan
    Zeng, Xinchen
    Tang, Jianxin
    Liang, Ziming
    Qi, Xiaofang
    Huang, Lujia
    Pang, Fei
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E16196 - E16196
  • [37] A Prospective Clinical Study on Early Recurrence of Hepatocellular Carcinoma After Hepatectomy
    Lu, Xin
    Zhao, Haitao
    Yang, Huayu
    Mao, Yilei
    Sang, Minting
    Miao, Ruoyu
    Xu, Yiyao
    Du, Shunda
    Xu, Haifeng
    Chi, Tianyi
    Yang, Zhiying
    Zhong, Shouxian
    Huang, Jiefu
    JOURNAL OF SURGICAL ONCOLOGY, 2009, 100 (06) : 488 - 493
  • [38] The Prognostic Role of Preoperative Neutrophil-Lymphocyte Ratio in Patients with Hepatocellular Carcinoma After Curative Hepatectomy: Possible Association with Tumor
    Choi, Sangjoon
    Ha, Sang Yun
    MODERN PATHOLOGY, 2018, 31 : 629 - 629
  • [39] Filamin A expression predicts early recurrence of hepatocellular carcinoma after hepatectomy
    Donadon, M.
    Di Tommaso, L.
    Soldani, C.
    Franceschini, B.
    Vitali, E.
    Roncalli, M.
    Lleo, A.
    Lania, A.
    Torzilli, G.
    DIGESTIVE AND LIVER DISEASE, 2018, 50 (01) : 38 - 39
  • [40] Filamin A expression predicts early recurrence of hepatocellular carcinoma after hepatectomy
    Donadon, Matteo
    Di Tommaso, Luca
    Soldani, Cristiana
    Franceschini, Barbara
    Terrone, Alfonso
    Mimmo, Antonio
    Vitali, Eleonora
    Roncalli, Massimo
    Lania, Andrea
    Torzilli, Guido
    LIVER INTERNATIONAL, 2018, 38 (02) : 303 - 311
12345